China is now the world's pharmaceutical raw materials supply center, and the development of the supply of the drug from the formulation to the trend of supply. In order to support the healthy and smooth development of China's pharmaceutical industry, Brazil and Italy to avoid the loss of national pharmaceutical industry lessons, Shinco Consulting in Chinese pharmaceutical industry globalization this critical period of development, and actively guide China's export-oriented vision has the ability to take the initiative to pharmaceutical companies, scientific understanding of the international GMP norms and drug Market Access system. Shinco consulting with international partners to join a professional, in just a few years, including the US / EU / WHO GMP consulting, certification, training, auditing, and API / drug registration document preparation and reporting (COS, DMF, EDMF, ANDA) several aspects of the business including professional services did very well, more than 200 customers throughout the country. Welcome to have genuine talent, professionals at home and abroad interested in the GMP-end consulting industry to join our elite team, a bright future, shared glory.

(Dr.Frank Cheng)